$abrdn Life Sciences Investors (HQL.US)$ 10% Shareholder Saba Capital Management, L.P. purchased 100 shares of common stock on Jun 26, 2024 at an average price of $14.07 for a total value of $1,407.
This transaction involves other related parties: Weinstein Boaz.
What is statement of changes in beneficial ownership of securities?
It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.
